Rachel Wong

Initial experience of TAS-102 chemotherapy in Australian patients with Chemo-refractory metastatic colorectal cancer

A Jalali, G Gard, S Banks, C Dunn, HL Wong, R Wong, M Lee, L Gately, M Loft, JD Shapiro, S Kosmider, J Tie, S Ananda, JM Yeung, R Jennens, B Lee, J McKendrick, L Lim, A Khattak, P Gibbs

Journal article  |  2021  |  Current Problems in Cancer

Real-world outcomes for neoadjuvant capecitabine versus infusional 5-fluorouracil in the treatment of locally advanced rectal cancer

Matthew Loft, Hui-Li Wong, Suzanne Kosmider, Margaret Lee, Jeanne Tie, Rachel Wong, Ian T Jones, Matthew Croxford, Malcolm Steel, Ian Faragher, Mario Guerrieri, Michael Christie, Peter Gibbs

Journal article  |  2021  |  INTERNAL MEDICINE JOURNAL

BACKGROUND: Neoadjuvant chemoradiation therapy is standard-of-care treatment for locally advanced rectal cancer (LARC). A patholog..

Stage dependent recurrence patterns and post-recurrence outcomes in non-metastatic colon cancer

Lucy Gately, Azim Jalali, Christine Semira, Ian Faragher, Matthew Croxford, Sumitra Ananda, Suzanne Kosmider, Kathryn Field, Sheau Wen Lok, Grace Gard, Malcolm Steel, Margaret Lee, Rachel Wong, Hui-Li Wong, Peter Gibbs

Journal article  |  2021  |  ACTA ONCOLOGICA

BACKGROUND: Multiple meta-analyses have demonstrated that routine surveillance following colorectal cancer surgery improves surviv..

Treatment and Outcomes of Oligometastatic Colorectal Cancer Limited to Lymph Node Metastases.

Vinod Kalapurackal Mathai, Soe Yu Aung, Vanessa Wong, Catherine Dunn, Jeremy Shapiro, Azim Jalali, Rachel Wong, Margaret Lee, Jeanne Tie, Sumitra Ananda, Suzanne Kosmider, Stephanie H Lim, Susan Caird, Matthew Burge, Andrew Dean, Peter Gibbs, Louise Nott

Journal article  |  2021  |  Clin Colorectal Cancer

INTRODUCTION: The optimal management of isolated distant lymph node metastases (IDLNM) from a colorectal primary, is not clearly e..

Circulating Tumour DNA as a Potential Cost-Effective Biomarker to Reduce Adjuvant Chemotherapy Overtreatment in Stage II Colorectal Cancer

Yat Hang To, Koen Degeling, Suzanne Kosmider, Rachel Wong, Margaret Lee, Catherine Dunn, Grace Gard, Azim Jalali, Vanessa Wong, Maarten IJzerman, Peter Gibbs, Jeanne Tie

Journal article  |  2021  |  PHARMACOECONOMICS

BACKGROUND AND OBJECTIVE: Substantial adjuvant chemotherapy (AC) overtreatment for stage II colorectal cancer results in a health ..

Bridging the gap: a pre-post feasibility study of embedding exercise therapy into a co-located cancer unit.

Amy M Dennett, Bernadette Zappa, Rachel Wong, Stephen B Ting, Kimberley Williams, Casey L Peiris

Journal article  |  2021  |  Support Care Cancer

PURPOSE: To establish the feasibility of embedding a flexible, exercise-based rehabilitation program into a cancer treatment unit ..

Circulating tumor DNA dynamics and recurrence risk in patients undergoing curative intent resection of colorectal cancer liver metastases: A prospective cohort study

Jeanne Tie, Yuxuan Wang, Joshua Cohen, Lu Li, Wei Hong, Michael Christie, Hui Li Wong, Suzanne Kosmider, Rachel Wong, Benjamin Thomson, Julian Choi, Adrian Fox, Kathryn Field, Matthew Burge, Jenny Shannon, Dusan Kotasek, Niall C Tebbutt, Christos Karapetis, Craig Underhill, Andrew Haydon, et al.

Journal article  |  2021  |  PLOS MEDICINE

BACKGROUND: In patients with resectable colorectal liver metastases (CRLM), the role of pre- and postoperative systemic therapy co..

Patient demographics and management landscape of metastatic colorectal cancer in the third-line setting: Real-world data in an australian population

Sandy Tun Min, Aflah Roohullah, Annette Tognela, Azim Jalali, Margaret Lee, Rachel Wong, Jeremy Shapiro, Matthew Burge, Desmond Yip, Louise Nott, Allan Zimet, Belinda Lee, Andrew Dean, Simone Steel, Hui-Li Wong, Peter Gibbs, Stephanie Hui-Su Lim

Journal article  |  2021  |  ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

BACKGROUND: Colorectal cancer is the third most common cancer and second leading cause of cancer mortality in Australia, thus carr..

Dual Antiangiogenesis Agents Bevacizumab Plus Trebananib, without Chemotherapy, in First-line Treatment of Metastatic Colorectal Cancer: Results of a Phase II Study

Jennifer Mooi, Fiona Chionh, Peter Savas, Jessica Da Gama Duarte, Geoffrey Chong, Stephen Brown, Rachel Wong, Timothy J Price, Alysson Wann, Effie Skrinos, John M Mariadason, Niall C Tebbutt

Journal article  |  2021  |  CLINICAL CANCER RESEARCH

PURPOSE: To assess the efficacy and safety of dual antiangiogenesis agents, bevacizumab plus trebananib, without chemotherapy, in ..

Cancer clinical trial vs real-world outcomes for standard of care first-line treatment in the advanced disease setting

Louise Kostos, Wei Hong, Belinda Lee, Ben Tran, Sheau Wen Lok, Angelyn Anton, Grace Gard, Yat Hang To, Vanessa Wong, Jeremy Shapiro, Rachel Wong, Shirley Wong, Richard de Boer, Peter Gibbs

Journal article  |  2021  |  INTERNATIONAL JOURNAL OF CANCER

Clinical trials have strict eligibility criteria, potentially limiting external validity. However, while often discussed this has ..